Navigation Links
Schering-Plough Reports Top-Line Results of the IDEAL Study
Date:1/14/2008

urticaria, angioedema, bronchoconstriction, anaphylaxis, retinal hemorrhages, and cotton wool spots.

In the PEGINTRON/REBETOL combination trial, the incidence of serious adverse events was 17% in the PEGINTRON/REBETOL groups compared to 14% in the INTRON A/ REBETOL group. The incidence of severe adverse events in the PEGINTRON/REBETOL combination therapy trial was 23% in the INTRON A/REBETOL group and 31-34% in the PEGINTRON/REBETOL groups. Dose reductions due to adverse reactions occurred in 42% of patients receiving PEGINTRON (1.5 mcg/kg)/REBETOL and in 34% of those receiving INTRON A/REBETOL.

Additional Safety Information

Relapse of drug addiction/overdose has occurred in patients on PEGINTRON therapy. Aggressive behavior sometimes directed towards others has occurred in patients with and without a previous psychiatric disorder during PEGINTRON and/or INTRON A treatment and follow-up. If patients develop psychiatric problems, including clinical depression, it is recommended that patients be carefully monitored during treatment and in the 6-month follow-up period. If psychiatric symptoms persist or worsen, or suicidal ideation or aggressive behavior towards others is identified, it is recommended that treatment with PEGINTRON and/or INTRON A be discontinued, and the patient be carefully followed with psychiatric intervention, as appropriate. Cases of encephalopathy have been observed in some patients, usually elderly, treated with higher doses of PEGINTRON and/or INTRON A. Ischemic and hemorrhagic cerebrovascular events have been observed in patients treated with interferon alpha therapies, including PEGINTRON and INTRON A. Dental and periodontal disorders have been reported in patients receiving PEGINTRON or INTRON A in combination with REBETOL therapy.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with par
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
2. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Second Thoughts about Fluoride, Reports Scientific American
6. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
7. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
8. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
9. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
10. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
11. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today ... at 1802 South First St. in the Temple Medical and ... City of Temple to receive funding for ... Texas Veterans Health Care System, the new facility will enable ... biotechnology and life science companies. ...
(Date:3/27/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is launching ... Available in both small (6mm) and large ... System from Zimmer is a modular system that offers surgeons ... XtraFix System allows surgeons to eliminate steps, as well ... in saved time, costs and overall team effort. ...
(Date:3/27/2015)... 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its previously announced registered offering of common shares in ... Pursuant to the Offering, the Company issued 7,286,432 common ... aggregate gross proceeds of approximately $1.45 billion. On March ... and Exchange Commission a final prospectus supplement to its ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3
... Endo Pharmaceuticals (Nasdaq: ENDP ) will announce ... and will host a conference call and webcast at 10:00 ... David P. Holveck, president and CEO of Endo, Julie ... of R&D, Alan Levin, executive vice president and chief financial ...
... With the launch of MEDI PORT, ... converge all forms of communication and collaboration with patient ... healthcare professionals can diagnose or treat a patient with ... professional,s location.   MEDI PORT is a ...
Cached Medicine Technology:Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010 2C PORT Solutions Launches MEDI PORT to Bring Powerful New Telemedicine Solutions to the Hospital Bedside 2C PORT Solutions Launches MEDI PORT to Bring Powerful New Telemedicine Solutions to the Hospital Bedside 3
(Date:3/29/2015)... Birmingham, Lake Orion, Clarkston, Metamora, MI. (PRWEB) March 29, ... affiliated with Beaumont Hospital , offers comprehensive endometriosis ... now offer patients in that area a closer hospital ... St. Joseph Mercy Oakland and McLaren Oakland. ... tissue that normally lines the inside of the uterus ...
(Date:3/29/2015)... March 30, 2015 Telerad RxDx ... the coveted NABH Accreditation on 11th January 2015. ... Hospitals and Healthcare Providers) comes as a true ... standards of Telerad RxDx., With Telerad RxDx being ... accredited for NABH, marks a major achievement and ...
(Date:3/29/2015)... The Claudia Cohen Research Foundation ... announce today that Dr. Beth Y. Karlan has been ... Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 ... Oncology 46th Annual Meeting on Women's Cancer in Chicago. ... Cancer Program at the Samuel Oschin Comprehensive Cancer Institute ...
(Date:3/29/2015)... The federal court overseeing hundreds ... in the U.S. District Court, Northern District of ... Conference for April 21st at 1:30 p.m. Court ... progress of product liability claims filed on behalf ... and other cardiovascular complications due to their use ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Youth Villages ... counties in Oregon to assess the feasibility of implementing ... emotional and behavioral problems and their families. , Third ... select participants that will be provided technical assistance throughout ... counties join six other national awardees chosen by Third ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Endometriosis 2Health News:NABH Accreditation for Telerad RxDx – Whitefield. 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4
... , Jan. 15 Healthcare Data Services (HDS) ... Quality Care Alliance (NEQCA), Tufts Medical Center Physicians Organization, to ... their proprietary HDS Analyst(SM) tool. The contract was established following ... the data monitoring needs of NEQCA and Tufts Medical Center ...
... Social status is intimately linked with health-related risk factors. ... , Thomas Lampert, of the Robert Koch Institute (RKI) ... and obesity are associated with social status (Dtsch Arztebl ... of social status-specific differences stemmed from the RKI,s Telephone ...
... in adulthood, researchers say , FRIDAY, Jan. 15 (HealthDay ... memory defects in adulthood, new research in rats suggests. ... to develop learning and memory deficits. It hasn,t been ... help the kids grow taller -- can help fend ...
... RALEIGH, N.C. , Jan. 15 PRA International, a ... client-facing portal into Oracle® Remote Data Capture (RDC) for its early ... and the United States . Through the portal, clients ... The portal provides sponsors with the ability to review all entered ...
... reasonable to obtain a histological diagnosis before treating patients ... to undergo surgery. As the pancreas is a deep ... a challenge for the physician to obtain an adequate ... masses has been proved to be a safe and ...
... ... co-founder and Chief Executive Officer Sean Lynch will be speaking at the McGuire ... The event takes place on February 11, 2010 at the Palmer House ... the conference, addressing managing costs and improving revenues in healthcare services. , ...
Cached Medicine News:Health News:Healthcare Data Services (HDS) Announces Contract with the New England Quality Care Alliance (NEQCA), the Physicians Organization of Tufts Medical Center 2Health News:Healthcare Data Services (HDS) Announces Contract with the New England Quality Care Alliance (NEQCA), the Physicians Organization of Tufts Medical Center 3Health News:PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies 2Health News:Anesthesia Healthcare Partners CEO to Speak at Upcoming Healthcare Conference to Offer Insight on Managing Costs in Healthcare Services 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: